Riociguat-Discontinue Effects on Right HEART in CTEPH (RED-HEART)

PHASE3RecruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

March 21, 2025

Primary Completion Date

October 30, 2026

Study Completion Date

October 31, 2027

Conditions
Chronic Thromboembolic Pulmonary Hypertension
Interventions
DRUG

Riociguat

On the basis of the comprehensive treatment in line with the guidelines, including conventional diuresis, anticoagulation, oxygen inhalation, etc., continue oral administration of riociguat for treatment.

DRUG

Routine Treatment

On the basis of the comprehensive treatment in line with the guidelines, including conventional diuresis, anticoagulation, oxygen inhalation, etc, and stop taking riociguat

Trial Locations (3)

100020

RECRUITING

Beijing Chao-Yang Hospital, Beijing

100029

RECRUITING

China-Japan Friendship Hospital, Beijing

101118

RECRUITING

Beijing Anzhen Hospital, Beijing

All Listed Sponsors
collaborator

China-Japan Friendship Hospital

OTHER

collaborator

Beijing Anzhen Hospital

OTHER

lead

Suqiao Yang

OTHER